These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36552969)

  • 41. The clinical utility of QSM: disease diagnosis, medical management, and surgical planning.
    Eskreis-Winkler S; Zhang Y; Zhang J; Liu Z; Dimov A; Gupta A; Wang Y
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27906525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magnetic Susceptibility Source Separation Solely from Gradient Echo Data: Histological Validation.
    Dimov AV; Gillen KM; Nguyen TD; Kang J; Sharma R; Pitt D; Gauthier SA; Wang Y
    Tomography; 2022 Jun; 8(3):1544-1551. PubMed ID: 35736875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of quantitative susceptibility mapping methods on evaluating radiation-induced cerebral microbleeds and basal ganglia at 3T and 7T.
    Chen Y; Genc O; Poynton CB; Banerjee S; Hess CP; Lupo JM
    NMR Biomed; 2022 May; 35(5):e4666. PubMed ID: 35075701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of abnormal iron distribution in specific regions in the brains of patients with Parkinson's disease using quantitative susceptibility mapping and R2
    Cheng Q; Huang J; Liang J; Ma M; Zhao Q; Lei X; Shi C; Luo L
    Exp Ther Med; 2020 Jun; 19(6):3778-3786. PubMed ID: 32346442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multisite reproducibility of quantitative susceptibility mapping and effective transverse relaxation rate in deep gray matter at 3 T using locally optimized sequences in 24 traveling heads.
    Naji N; Lauzon ML; Seres P; Stolz E; Frayne R; Lebel C; Beaulieu C; Wilman AH
    NMR Biomed; 2022 Nov; 35(11):e4788. PubMed ID: 35704837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recommended Implementation of Quantitative Susceptibility Mapping for Clinical Research in The Brain: A Consensus of the ISMRM Electro-Magnetic Tissue Properties Study Group.
    ; Bilgic B; Costagli M; Chan KS; Duyn J; Langkammer C; Lee J; Li X; Liu C; Marques JP; Milovic C; Robinson S; Schweser F; Shmueli K; Spincemaille P; Straub S; van Zijl P; Wang Y;
    ArXiv; 2023 Jul; ():. PubMed ID: 37461418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative susceptibility mapping as an imaging biomarker for Alzheimer's disease: The expectations and limitations.
    Uchida Y; Kan H; Sakurai K; Oishi K; Matsukawa N
    Front Neurosci; 2022; 16():938092. PubMed ID: 35992906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Susceptibility-sensitive MRI of multiple sclerosis lesions and the impact of normal-appearing white matter changes.
    Wiggermann V; Hametner S; Hernández-Torres E; Kames C; Endmayr V; Kasprian G; Höftberger R; Li DKB; Traboulsee A; Rauscher A
    NMR Biomed; 2017 Aug; 30(8):. PubMed ID: 28470768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of iron oxide nanoparticle (IONP)-labeled stem cells using quantitative ultrashort echo time imaging: a feasibility study.
    Athertya JS; Akers J; Sedaghat S; Wei Z; Moazamian D; Dwek S; Thu M; Jang H
    Quant Imaging Med Surg; 2023 Feb; 13(2):585-597. PubMed ID: 36819276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hematoma volume measurement in gradient echo MRI using quantitative susceptibility mapping.
    Wang S; Lou M; Liu T; Cui D; Chen X; Wang Y
    Stroke; 2013 Aug; 44(8):2315-7. PubMed ID: 23704111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validation of liver quantitative susceptibility mapping across imaging parameters at 1.5 T and 3.0 T using SQUID susceptometry as reference.
    Zhao R; Velikina J; Reeder SB; Vasanawala S; Jeng M; Hernando D
    Magn Reson Med; 2023 Apr; 89(4):1418-1428. PubMed ID: 36408802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Integration of Quantitative Susceptibility Mapping Magnetic Resonance Imaging into Neurosurgical Practice.
    Bandt SK; de Rochefort L; Chen W; Dimov AV; Spincemaille P; Kopell BH; Gupta A; Wang Y
    World Neurosurg; 2019 Feb; 122():e10-e19. PubMed ID: 30201583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative Susceptibility Mapping and Vessel Wall Imaging as Screening Tools to Detect Microbleed in Sentinel Headache.
    Ishii D; Nakagawa D; Zanaty M; Roa JA; Al Kasab S; Shaban A; Hudson JS; Osorno-Cruz C; Byer S; Allan L; Torner JC; Awad IA; Carroll TJ; Samaniego EA; Hasan DM
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32244737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing robustness of quantitative susceptibility-based MRI radiomic features in patients with multiple sclerosis.
    Fiscone C; Rundo L; Lugaresi A; Manners DN; Allinson K; Baldin E; Vornetti G; Lodi R; Tonon C; Testa C; Castelli M; Zaccagna F
    Sci Rep; 2023 Sep; 13(1):16239. PubMed ID: 37758804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delineation of prostatic calcification using quantitative susceptibility mapping: Spatial accuracy for magnetic resonance-only radiotherapy planning.
    Kan H; Tsuchiya T; Yamada M; Kunitomo H; Kasai H; Shibamoto Y
    J Appl Clin Med Phys; 2022 Feb; 23(2):e13469. PubMed ID: 34726833
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro-magnetic tissue properties study group.
    ; Bilgic B; Costagli M; Chan KS; Duyn J; Langkammer C; Lee J; Li X; Liu C; Marques JP; Milovic C; Robinson SD; Schweser F; Shmueli K; Spincemaille P; Straub S; van Zijl P; Wang Y;
    Magn Reson Med; 2024 May; 91(5):1834-1862. PubMed ID: 38247051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Research Progress of Quantitative Susceptibility Mapping in MRI].
    Wang S; Duan C; Zhang P; Wang C; Liu X; Li H; Cheng J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Oct; 32(5):1131-4. PubMed ID: 26964324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.
    Wang Y; Liu T
    Magn Reson Med; 2015 Jan; 73(1):82-101. PubMed ID: 25044035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural and functional quantitative susceptibility mapping from standard fMRI studies.
    Sun H; Seres P; Wilman AH
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 27687150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.
    Lim IA; Faria AV; Li X; Hsu JT; Airan RD; Mori S; van Zijl PC
    Neuroimage; 2013 Nov; 82():449-69. PubMed ID: 23769915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.